MX2010003618A - Lisina de aztreonam inhalada para el tratamiento de deficits en la calidad de vida relacionada con la salud en enfermedades pulmonares. - Google Patents

Lisina de aztreonam inhalada para el tratamiento de deficits en la calidad de vida relacionada con la salud en enfermedades pulmonares.

Info

Publication number
MX2010003618A
MX2010003618A MX2010003618A MX2010003618A MX2010003618A MX 2010003618 A MX2010003618 A MX 2010003618A MX 2010003618 A MX2010003618 A MX 2010003618A MX 2010003618 A MX2010003618 A MX 2010003618A MX 2010003618 A MX2010003618 A MX 2010003618A
Authority
MX
Mexico
Prior art keywords
health
deficits
treatment
life
related quality
Prior art date
Application number
MX2010003618A
Other languages
English (en)
Spanish (es)
Inventor
Alan Montgomery
Melissa Yeager
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of MX2010003618A publication Critical patent/MX2010003618A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2010003618A 2007-10-01 2008-09-15 Lisina de aztreonam inhalada para el tratamiento de deficits en la calidad de vida relacionada con la salud en enfermedades pulmonares. MX2010003618A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99707207P 2007-10-01 2007-10-01
US99707107P 2007-10-01 2007-10-01
PCT/US2008/076431 WO2009045706A1 (en) 2007-10-01 2008-09-15 Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of life in lung diseases

Publications (1)

Publication Number Publication Date
MX2010003618A true MX2010003618A (es) 2010-04-21

Family

ID=40032482

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003618A MX2010003618A (es) 2007-10-01 2008-09-15 Lisina de aztreonam inhalada para el tratamiento de deficits en la calidad de vida relacionada con la salud en enfermedades pulmonares.

Country Status (15)

Country Link
US (1) US7973029B2 (enExample)
EP (1) EP2200608A1 (enExample)
JP (1) JP2010540539A (enExample)
KR (1) KR20100093037A (enExample)
CN (1) CN101951906A (enExample)
AR (1) AR068514A1 (enExample)
AU (1) AU2008307268A1 (enExample)
BR (1) BRPI0817636A2 (enExample)
CA (1) CA2701118A1 (enExample)
EA (1) EA201070336A1 (enExample)
IL (1) IL204593A0 (enExample)
MX (1) MX2010003618A (enExample)
NZ (1) NZ584269A (enExample)
TW (1) TW200927193A (enExample)
WO (1) WO2009045706A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214364B2 (en) 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
DK2301524T3 (da) 2000-12-27 2013-07-15 Gilead Sciences Inc Inhalerbar aztreonam uden arginin til behandling og forebyggelse af bakterielle lungeinfektioner
CN104784159A (zh) * 2015-04-15 2015-07-22 苏州惠仁生物科技有限公司 氨曲南粉雾剂的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5152456A (en) 1989-12-12 1992-10-06 Bespak, Plc Dispensing apparatus having a perforate outlet member and a vibrating device
EP0615470B1 (en) 1991-12-04 1995-12-13 The Technology Partnership Public Limited Company Fluid droplet production apparatus and method
DE19953317C1 (de) 1999-11-05 2001-02-01 Pari Gmbh Inhalationsvernebler
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
US7214364B2 (en) 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
US7138419B2 (en) * 2000-12-27 2006-11-21 Corus Pharma, Inc. Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
DK2301524T3 (da) 2000-12-27 2013-07-15 Gilead Sciences Inc Inhalerbar aztreonam uden arginin til behandling og forebyggelse af bakterielle lungeinfektioner
DE10102846B4 (de) 2001-01-23 2012-04-12 Pari Pharma Gmbh Aerosolgenerator

Also Published As

Publication number Publication date
BRPI0817636A2 (pt) 2019-09-24
IL204593A0 (en) 2010-11-30
US7973029B2 (en) 2011-07-05
AR068514A1 (es) 2009-11-18
CN101951906A (zh) 2011-01-19
TW200927193A (en) 2009-07-01
NZ584269A (en) 2012-06-29
JP2010540539A (ja) 2010-12-24
EP2200608A1 (en) 2010-06-30
CA2701118A1 (en) 2009-04-09
EA201070336A1 (ru) 2011-06-30
KR20100093037A (ko) 2010-08-24
US20090124594A1 (en) 2009-05-14
WO2009045706A1 (en) 2009-04-09
AU2008307268A1 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
MX2023001592A (es) Inhalador de polvo seco.
SI1765349T1 (sl) Opioidi za zdravljenje kronične obstrukcijske pljučne bolezni (KOPB)
NZ599928A (en) Use of pentosan polysulfate for treatment or prophylaxis of asthma
NZ713202A (en) Diagnosis and treatments relating to th2 inhibition
WO2012041938A3 (en) Inhaler
ECSP11010971A (es) Tratamiento de la diabetes en pacientes con control glucemico insuficiente a pesar de la terapia con un fármaco oral o no oral antidiabético
NZ606977A (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
MX2012007813A (es) Tratamiento del sindrome de apnea obstructiva del sueño con una combinacion de un hinibidor de anhidrasa carbonica y un agente activo adicional.
EA201201392A1 (ru) Кнопочное устройство мундштука ингалятора сухого порошка
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
EA201201395A1 (ru) Кнопочное устройство мундштука ингалятора сухого порошка
NZ599511A (en) Recombinant human cc10 protein for treatment of influenza
NO20073909L (no) Forstover-formulering
GB0620385D0 (en) Novel compounds
EA201791732A1 (ru) Безопасное введение десмопрессина
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
EA201070336A1 (ru) Ингаляционный азтреонам лизин для лечения нарушений, снижающих качество жизни, обусловленное состоянием здоровья при заболеваниях легких
NO20082439L (no) Anvendelse av tiotropiumsalter for behandling av moderat vedvarende astma
NZ603040A (en) Compound for treatment of respiratory condition or disease
EA200701077A1 (ru) Применение конъюгатов липидов при лечении заболеваний
MEP51608A (en) Pulverulent formulation for inhalation containing tiotropium
DE602008006024D1 (de) Verwendung von natriumblockern zur frühzeitigen behandlung von obstruktiven lungenerkrankungen
TN2011000356A1 (en) Dimeric pyrrolopyrimidinedione and its use in therapy of respiratory diseases
HK1145801A (en) Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of life in lung diseases
JP1727648S (ja) 医療用酸素濃縮器

Legal Events

Date Code Title Description
FA Abandonment or withdrawal